Parkinson's Disease Clinical Trials

Showing 1581-1600 of 1,818 trials

Deep Brain Stimulation for Parkinson's Disease Trial

NCT00053625

The purpose of this trial is to evaluate the effect of deep brain stimulation in the the globus pallidus (Gpi) and the subthalamic nucleus (STN) on motor, neuropsychological and psychiatric function, and quality of life in patients with Parkinson's disease.

Parkinson's Disease

University of Minnesota123 participantsStarted Jun 1999

Atlanta, Georgia, United States • Cleveland, Ohio, United States

TERMINATEDPhase 3

NET-PD LS-1 Creatine in Parkinson's Disease

NCT00449865

The purpose of this trial is to determine if the nutritional supplement creatine slows the progression of Parkinson's disease over time.

Parkinson's Disease

University of Rochester1,741 participantsStarted Mar 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Fountain Valley, California, United States +47 more locations

Deep Brain Stimulation for Parkinson's Disease Trial

NET-PD LS-1 Creatine in Parkinson's Disease

Related Searches

An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance Performance in Parkinsonian Non-fallers and Single Fallers

Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

The Effect of Exercise on Individuals With Parkinson's Disease

Whole-body Vibration as a Treatment for Parkinson's Disease

Single Ascending Dose Study of PRX002 in Healthy Subjects

The Effect of Rasagiline on Cognition in Parkinson's Disease

An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease

Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease

Coping With Depression in Parkinson's Disease

Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease